Digest Network Come funziona
Network
/
Società
In
Non verificato

Infinimmune

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

8 comunicati stampa

Guarda tutti i comunicati
05/10/2026
Multimedialità
Eventi
Biotecnologia
Salute
Scienza
Farmaceutica
Fierce Biotech, a division of Forge, names Infinimmune a “Fierce 15” Biotech Company of 2026
Fonte
Infinimmune
Emittente
Business Wire
1.00
0
11/08/2026
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Infinimmune Raises $75 Million Series A Financing to Advance Pipeline of Human-Derived Antibodies for Atopic Dermatitis and Inflammatory Disease
Fonte
Infinimmune
Emittente
Business Wire
1.00
0
13/05/2026
Infinimmune Appoints Srikanth Pendyala, M.D., as Chief Medical Officer
Fonte
Infinimmune
Emittente
Business Wire
1.00
0
27/04/2026
Infinimmune Appoints Anthony Slavin, Ph.D., as Senior Vice President of Portfolio Strategy
Fonte
Infinimmune
Emittente
Business Wire
1.00
0
31/03/2026
Mercato del lavoro
Salute
Scienza
Medicina - Varie
Farmaceutica
Biotecnologia
Infinimmune Enters Collaboration with Merck to Discover Novel Human Antibody Therapeutics
Fonte
Infinimmune
Emittente
Business Wire
1.00
0
18/09/2025
Scienza
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Farmaceutica
Salute
Oncologia
Mercato del lavoro
Industria
Infinimmune Announces Research Collaboration with Immunome
Fonte
Infinimmune
Emittente
Business Wire
1.00
0
12/06/2025
Scienza
Tecnica
Biotecnologia
Software
Farmaceutica
Salute
Industria
Infinimmune Launches GLIMPSE-1 AI Model Trained Exclusively on Human Antibody Sequences for Advanced Therapeutic Engineering
Fonte
Infinimmune
Emittente
Business Wire
1.00
0
03/09/2024
Multimedialità
Oncologia
Salute
Biotecnologia
Sanità
Medicina - Varie
Farmaceutica
Mercato del lavoro
Infinimmune Appoints Dr. Tim Sullivan as Chief Business Officer
Fonte
Infinimmune
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0